News | Cath Lab | April 25, 2022

NewYork-Presbyterian Hudson Valley Hospital Launches Interventional Cardiology Program and Opens State-of-the-Art Cardiac Catheterization Lab

The new interventional cardiology program will provide advanced cardiac intervention services, expanding access to the hospital’s team of leading specialists and expert care.
 

Celebrating the opening of new Interventional Cardiology Suite at NewYork-Presbyterian Hudson Valley Hospital

Celebrating the opening of new Interventional Cardiology Suite at NewYork-Presbyterian Hudson Valley Hospital


April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology program and the opening of its new cardiac catheterization laboratory, designed to support cardiac health and bring world-class interventional cardiology care to the Hudson Valley and upper Westchester region.

“NewYork-Presbyterian Hudson Valley Hospital and NewYork-Presbyterian Medical Group Hudson Valley cardiologists have been caring for our community’s hearts for decades,” said Stacey Petrower, president of NewYork-Presbyterian Hudson Valley Hospital. “We pride ourselves on serving our community, and are pleased to now be providing emergent life-saving intervention, in addition to diagnostic and preventive medical procedures, close to home.”

Dr. Giora Weisz
Dr. Giora Weisz, medical director of interventional cardiology at NewYork-Presbyterian Hudson Valley Hospital and an associate professor of medicine at Columbia University Vagelos College of Physicians and Surgeons.

“We look forward to further improving the cardiac care for residents of our surrounding communities and providing comprehensive on-site care for patients already treated at our hospital,” said Dr. Giora Weisz, medical director of interventional cardiology at NewYork-Presbyterian Hudson Valley Hospital and an associate professor of medicine at Columbia University Vagelos College of Physicians and Surgeons. “When it comes to cardiac emergencies, time is muscle. Having a catheterization lab close to home means patients will have speedier access to expert care, and that leads to better outcomes, especially for those experiencing a life-threatening event such as a heart attack.”

The interventional cardiology program provides a variety of emergent procedures, including cardiac angioplasty to improve blood flow in narrow or blocked arteries for patients experiencing a heart attack or chest pain. Advanced cardiac services include diagnostic cardiac catheterization (a procedure in which a catheter is guided through a blood vessel in the heart to diagnose certain heart conditions) and minimally invasive procedures to open clogged arteries. These include percutaneous coronary intervention (PCI, also known as ‘balloon and stent procedure’) and endovascular peripheral arterial revascularization, as well as electrophysiology (EP) procedure services to restore heart rhythms. The interventional cardiology program is equipped with the most up to date, state-of-the-art equipment including novel catheters to image the blood vessels from the inside. Additionally, physicians provide pacemaker and defibrillator implantation for treatment of arrhythmias.

NewYork-Presbyterian Hudson Valley Hospital’s interventional cardiology program will be open for emergent cases 24 hours a day, seven days a week, and will have a structured schedule for diagnostic and non-emergent procedures. Patients who may require cardiac surgery will have easy access to surgeons at NewYork-Presbyterian/Columbia University Irving Medical Center, establishing seamless team-oriented continuity of care.

The 8,500-square-foot facility was designed in collaboration with Jeffrey Berman Architect, OLA Consulting Engineers and Severud Associates, and is part of a broader initiative to enhance cardiac services across NewYork-Presbyterian's health system.

For more information: https://www.nyp.org/hudsonvalley

Related Content

News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
News | Cath Lab

November 10, 2021 — Shockwave Medical a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely ...

Home November 10, 2021
Home
News | Cath Lab

November 10, 2021 — Philips Healthcare announced North American availability of new innovations in its portfolio of ...

Home November 10, 2021
Home
News | Cath Lab

October 6, 2021 — Boston Scientific Corp. announced it entered into a definitive agreement to acquire Baylis Medical ...

Home October 06, 2021
Home
Subscribe Now